Allianz Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.25M Sell
36,990
-27,716
-43% -$5.38M 0.01% 1002
2025
Q4
$11.2M Sell
64,706
-93,144
-59% -$17M 0.01% 808
2025
Q3
$30.1M Sell
157,850
-146,511
-48% -$26M 0.03% 450
2025
Q2
$54.7M Sell
304,361
-84,694
-22% -$14.7M 0.07% 299
2025
Q1
$65.8M Sell
389,055
-131,556
-25% -$21.6M 0.09% 229
2024
Q4
$78.5M Sell
520,611
-95,252
-15% -$14.8M 0.1% 205
2024
Q3
$95.6M Buy
615,863
+320,763
+109% +$47.9M 0.13% 164
2024
Q2
$40.4M Buy
295,100
+34,572
+13% +$4.73M 0.06% 317
2024
Q1
$34.7M Buy
260,528
+21,372
+9% +$2.77M 0.05% 339
2023
Q4
$33M Buy
239,156
+5,285
+2% +$695K 0.05% 343
2023
Q3
$28.5M Buy
233,871
+68,625
+42% +$9.14M 0.05% 378
2023
Q2
$23.2M Buy
165,246
+29,543
+22% +$4.07M 0.04% 416
2023
Q1
$19.2M Sell
135,703
-106,531
-44% -$15.2M 0.03% 493
2022
Q4
$37.9M Sell
242,234
-15,918
-6% -$2.29M 0.07% 283
2022
Q3
$31.7M Sell
258,152
-33,178
-11% -$4.37M 0.06% 314
2022
Q2
$38.7M Buy
291,330
+1,572
+0.5% +$214K 0.04% 481
2022
Q1
$39.7M Buy
289,758
+149,261
+106% +$20.8M 0.03% 528
2021
Q4
$24.3M Sell
140,497
-29,337
-17% -$4.46M 0.02% 698
2021
Q3
$24.7M Sell
169,834
-174,435
-51% -$25.5M 0.02% 650
2021
Q2
$45.4M Sell
344,269
-170,463
-33% -$22.3M 0.04% 419
2021
Q1
$66.1M Sell
514,732
-358,805
-41% -$44.2M 0.06% 300
2020
Q4
$104M Buy
873,537
+90,419
+12% +$11M 0.1% 195
2020
Q3
$89.7M Buy
783,118
+220,845
+39% +$26.1M 0.1% 204
2020
Q2
$64.1M Sell
562,273
-87,774
-14% -$9.31M 0.07% 279
2020
Q1
$52.2M Sell
650,047
-350,069
-35% -$36.2M 0.07% 300
2019
Q4
$107M Buy
1,000,116
+45,174
+5% +$4.71M 0.1% 228
2019
Q3
$102M Sell
954,942
-590,562
-38% -$60.6M 0.1% 228
2019
Q2
$157M Sell
1,545,504
-331,475
-18% -$31.9M 0.15% 147
2019
Q1
$169M Sell
1,876,979
-106,622
-5% -$9.24M 0.17% 120
2018
Q4
$165M Buy
1,983,601
+92,647
+5% +$8.69M 0.18% 118
2018
Q3
$204M Sell
1,890,954
-133,319
-7% -$14.6M 0.18% 104
2018
Q2
$223M Sell
2,024,273
-293,256
-13% -$30.5M 0.22% 84
2018
Q1
$232M Buy
2,317,529
+177,299
+8% +$18.2M 0.22% 83
2017
Q4
$211M Buy
2,140,230
+114,752
+6% +$10.9M 0.17% 118
2017
Q3
$190M Buy
2,025,478
+193,475
+11% +$20.5M 0.16% 119
2017
Q2
$203M Sell
1,832,003
-197,387
-10% -$20.9M 0.2% 98
2017
Q1
$199M Sell
2,029,390
-367,174
-15% -$35M 0.19% 94
2016
Q4
$220M Sell
2,396,564
-1,018,541
-30% -$87.8M 0.2% 100
2016
Q3
$288M Sell
3,415,105
-169,160
-5% -$14.2M 0.28% 56
2016
Q2
$292M Sell
3,584,265
-922,487
-20% -$70.2M 0.31% 53
2016
Q1
$322M Buy
4,506,752
+318,345
+8% +$21.3M 0.37% 49
2015
Q4
$298M Buy
4,188,407
+3,442,605
+462% +$231M 0.34% 56
2015
Q3
$45.8M Sell
745,802
-34,060
-4% -$2.38M 0.05% 409
2015
Q2
$56.6M Buy
779,862
+140,707
+22% +$10.4M 0.06% 386
2015
Q1
$49.1M Buy
639,155
+232,329
+57% +$16.6M 0.06% 371
2014
Q4
$27.3M Buy
406,826
+64,817
+19% +$4.09M 0.03% 602
2014
Q3
$20.8M Buy
342,009
+142,186
+71% +$8.76M 0.03% 627
2014
Q2
$11.7M Buy
199,823
+30,420
+18% +$1.78M 0.01% 702
2014
Q1
$9.81M Buy
169,403
+270
+0.2% +$14.5K 0.01% 761
2013
Q4
$9.06M Buy
169,133
+56,355
+50% +$3.34M 0.01% 766
2013
Q3
$6.97M Buy
112,778
+5,808
+5% +$348K 0.01% 808
2013
Q2
$6.49M Buy
+106,970
New +$6.37M 0.01% 788

Other funds holding DGX

Allianz Asset Management's DGX Position: Q1 2026 in Review

Allianz Asset Management reduced its Quest Diagnostics (DGX) stake by 43% in Q1 2026, selling an estimated $5.38M and leaving 36,990 shares worth $7.25M. The position accounts for 0.01% of the portfolio, ranked #1002.

Allianz Asset Management first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $322M in Q1 2016. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Allianz Asset Management held 36,990 shares of Quest Diagnostics worth $7.25M as of Q1 2026.
  • Allianz Asset Management sold 27,716 Quest Diagnostics shares in Q1 2026, an estimated $5.38M.
  • Quest Diagnostics made up 0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1002 holding.
  • Allianz Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Allianz Asset Management's Quest Diagnostics position peaked at $322M in Q1 2016.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.